Metyrosine
- Product NDC
- 68682-310
- 11-digit product format
- 686820310
- Labeler code
- 68682
- Product ID
- 68682-310_e61c29ce-16b2-415c-b203-28bc9d45bb5f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metyrosine
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Oceanside Pharmaceuticals
- Application
- NDA017871
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2020-09-07
- Substance
- METYROSINE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Catecholamine Synthesis Inhibitor [EPC], Catecholamine Synthesis Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Metyrosine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| METYROSINE | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | DOQ0J0TPF7 |
| Rxcui | 197980 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68682-310-01 | Metyrosine | 100 in 1 BOTTLE | CAPSULE | 100 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68682-310 | METYROSINE CAPSULE [OCEANSIDE PHARMACEUTICALS] | 4 | Current NDC, Legacy NDC, 1 package rows | 20210915_46612725-bee0-4125-b8b5-9fed9c003ed4.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68682-310-01 | 68682031001 | 100 CAPSULE in 1 BOTTLE (68682-310-01) | 100 capsule | 2020-09-07 | 0000-00-00 | No | No | Current |